Intravenous to oral conversion of fluoroquinolones: Knowledge versus clinical practice patterns

Pharmacy World and Science

Volumn 24, Issue 2, 2002, Pages 67-70

  Conort, Ornella ^a   Fitzpatrick, Marie Pauline ^a   Hazebroucq, Georges ^a   Cariou, Alain ^b   Gabardi, Steven ^c,d  

^a université Paris Cité   (France)

^b Department of Medicine ^*  (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d NORTHEASTERN UNIVERSITY   (United States)

Author keywords

Chart review; Fluoroquinolones; France; Knowledge; Oral administration; Parental administration; Practice patterns

Indexed keywords

CIPROFLOXACIN; OFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; ANTIINFECTIVE AGENT; QUINOLONE DERIVATIVE;

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; CLINICAL PRACTICE; CLINICAL TRIAL; COMORBIDITY; FEMALE; FRANCE; HEALTH CARE QUALITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRESCRIPTION; QUESTIONNAIRE; WARD; ATTITUDE TO HEALTH; COMPARATIVE STUDY; ECONOMICS; INTRAVENOUS DRUG ADMINISTRATION; MIDDLE AGED; ORAL DRUG ADMINISTRATION; PHYSICIAN; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; STATISTICS;

ADMINISTRATION, ORAL; ADULT; AGED; ANTI-INFECTIVE AGENTS, FLUOROQUINOLONE; COMPARATIVE STUDY; FEMALE; HUMAN; INJECTIONS, INTRAVENOUS; KNOWLEDGE, ATTITUDES, PRACTICE; MALE; MIDDLE AGE; PHYSICIAN'S PRACTICE PATTERNS; PHYSICIANS; PROSPECTIVE STUDIES; QUESTIONNAIRES; RETROSPECTIVE STUDIES; ANTI-INFECTIVE AGENTS; FLUOROQUINOLONES; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MIDDLE AGED;

EID: 0036000279     PISSN: 09281231     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1015533503212     Document Type: Article

References (12)

1. Brief report: Sequential intravenous/oral therapy with ciprofloxacin in severe infection
2. Brief report: Randomized study of intravenous versus sequential intravenous/oral regimen of ciprofloxacin in the treatment of gram-negative septicemia
3. Severe infections treated with intravenous ofloxacin: A prospective clinical multicentre Swiss study
4. Randomized study of intravenous/oral ciprofloxacin versus ceftazidime in the treatment of hospital and nursing home patients with lower respiratory tract infections
5. Sequential parenteral and oral ciprofloxacin regimen versus parenteral therapy for bacteremia: A pharmacoeconomic analysis
6. Oral ciprofloxacin: A pharmacoeconomic evaluation of its use in the treatment of serious infections
7. Economic impact of oral ciprofloxacin following standard intravenous therapy
8. Clinical and economic evaluation of oral ciprofloxacin after an abbreviated course of intravenous antibiotics
9. Early switch from intravenous to oral antibiotics and early hospital discharge
10. Sequential antibiotics therapy: Effective cost management and patient care
11. A pharmacist-initiated program of intravenous to oral antibiotic conversion
12. Early switch from intravenous to oral antibiotics: Guidelines and implementation in a large teaching hospital